# Treatment patterns and persistence rates with anti‐vascular endothelial growth factor treatment for diabetic macular oedema in the UK: A real‐world study

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/treatment-patterns-and-persistence-rates-with-anti-vascular-endothelial-growth/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Tünde Pető,Toks Akerele,Alexandros Sagkriotis,Sofia Zappacosta,Andreas Clemens,Usha Chakravarthy |
| Citations | 36 |
| DOI | 10.1111/dme.14746 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dme.14746 |
| OpenAlex ID | https://openalex.org/W3212594963 |
| PMID | 34796985 |
| Type | article |
| Year | 2021 |

## Paper authors

- [Alexandros Sagkriotis](https://scholariq.org/researchers/alexandros-sagkriotis/)

## Paper primary topic

- [Retinal Diseases and Treatments](https://scholariq.org/topics/retinal-diseases-and-treatments/)

## Paper topics

- [Retinal Diseases and Treatments](https://scholariq.org/topics/retinal-diseases-and-treatments/)
- [Ophthalmology and Visual Impairment Studies](https://scholariq.org/topics/ophthalmology-and-visual-impairment-studies/)
- [Ocular Diseases and Behçet’s Syndrome](https://scholariq.org/topics/ocular-diseases-and-behcet-s-syndrome/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.